=

Biogen resurrects Alzheimer’s drug; shares jump 37%

111111111

October 22, 2019 0 Comments
Biogen is planning to file for U.S. regulatory approval for its Alzheimer’s treatment aducanumab after fresh analysis of its clinical trial showed promise, the drugmaker said.
Tags:
Share: